|
|
||||||||
Article |
1 From the University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh.
Over the past 40 y, several lines of investigation have shown that the chemistry and function of both the developing and the mature brain are influenced by diet. Examples are the effect of folate deficiency on neural tube development during early gestation, the influence of essential fatty acid deficiency during gestation and postnatal life on the development of visual function in infants, and the effects of tryptophan or tyrosine intake (alone or as a constituent of dietary protein) on the production of the brain neurotransmitters derived from them (serotonin and the catecholamines, respectively). Sometimes the functional effects are clear and the underlying biochemical mechanisms are not (as with folate and essential fatty acids); in other cases (such as the amino acids tyrosine and tryptophan), the biochemical effects are well understood, whereas the effect on brain function is not. Despite the incomplete knowledge base on the effects of such nutrients, investigators, physicians, and regulatory bodies have promoted the use of these nutrients in the treatment of disease. Typically, these nutrients have been given in doses above those believed to be required for normal health; after they have been given in pure form, unanticipated adverse effects have occasionally occurred. If this pharmacologic practice is to continue, it is important from a public safety standpoint that each nutrient be examined for potential toxicities so that appropriate purity standards can be developed and the risks weighed against the benefits when considering their use.
Key Words: Polyunsaturated fatty acid PUFA folic acid tyrosine tryptophan choline brain brain development affective disorders Parkinson disease Alzheimer disease dietary supplements
This article has been cited by other articles:
![]() |
I. Bjelland, G. S. Tell, S. E. Vollset, H. Refsum, and P. M. Ueland Folate, Vitamin B12, Homocysteine, and the MTHFR 677C->T Polymorphism in Anxiety and Depression: The Hordaland Homocysteine Study Arch Gen Psychiatry, June 1, 2003; 60(6): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bier Amino Acid Pharmacokinetics and Safety Assessment J. Nutr., June 1, 2003; 133(6): 2034S - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W Solomons Ross Conference had too narrow a representation to speak about matters of the world Am. J. Clinical Nutrition, March 1, 2001; 73(3): 654 - 655. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |